Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hospital costs associated with complications following pancreatoduodenectomy: systematic review.

BJS open·2026
Same author

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials.

JCO oncology practice·2026
Same author

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same author

Tumor microbial burden drives immune responses through regulation of Interferon signaling.

Cancer discovery·2026
Same author

Long-term Outcomes After Resection of Solitary Colorectal Liver Metastases.

Annals of surgical oncology·2026

相关实验视频

Updated: Jan 14, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K

肝脏内胆管癌:复发模式,基因组学和生存情况

Pratik Chandra1, Yi Song1, Esther Drill2

  • 1Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY.

JCO precision oncology
|October 23, 2025
PubMed
概括

肝内胆固醇癌 (IHC) 切除后的复发是常见的. 同时的肝脏和肝外复发预示着比仅肝脏或肝外复发更糟糕的生存率,这表明有针对性的辅助疗法可能会改善结果.

更多相关视频

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.4K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.9K

相关实验视频

Last Updated: Jan 14, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K
A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.4K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.9K

科学领域:

  • 在瘤学瘤学.
  • 手术瘤学手术瘤学
  • 基因组学就是基因组学.

背景情况:

  • 肝脏内胆固醇癌 (IHC) 的复发模式和基因组驱动因素仍然不完全理解.
  • 第一次复发部位对手术切除后患者结局的影响还不清楚.

研究的目的:

  • 为了研究第一个复发部位对肝脏内胆固醇癌 (IHC) 切除后的整体存活期 (OS) 的影响.
  • 探索与切除IHC的复发模式和结果相关的基因组基础.

主要方法:

  • 从有可用的基因组数据的两个机构对318名切除IHC的患者进行了回顾性分析.
  • 第一次复发部位的分类:仅肝脏 (LO),仅肝外 (EH),或同时肝脏和肝外 (SIM).
  • 从复发时间计算整体存活 (OS) 和与临床病理学和基因组因素的相关性.

主要成果:

  • 在232名复发患者中,LO (40%),EH (34%) 和SIM (26%) 是复发部位.
  • 与LO (33个月) 和EH (33个月) 相比,SIM (12个月) 的中位数从复发的OS显著较低 (P < .001).
  • TP53突变,CDKN2A删除,CDKN2B删除和KRAS突变与更糟糕的生存状况有关;SIM复发,N1状态和高风险基因型独立预测了较差的生存状况.

结论:

  • 同时的肝脏和肝外复发与IHC切除后的存活率显著降低有关.
  • 临床病理学和基因组因素显示,预测首次复发地点的能力有限.
  • 针对肝脏复发的辅助策略可能有利于改善切除IHC患者的结果.